| |
| |
|
| Insider
Information: |
Root Jonathan D |
| Relationship: |
10% Owner |
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
652,550 |
|
|
Indirect Shares
|
141,997 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$306,597 |
|
|
| Total
Shares |
794,547 |
|
|
| Total
Value |
$306,597 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -125.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Occam Networks Inc |
OCNW |
10% Owner |
2007-02-23 |
538 |
2007-02-23 |
0 |
Premium* |
|
|
Maxlinear Inc |
MXL |
10% Owner |
2011-02-15 |
0 |
2011-02-15 |
2,220 |
Premium* |
|
|
Atricure, Inc. |
ATRC |
10% Owner |
2012-06-06 |
0 |
2012-06-13 |
11,873 |
Premium* |
|
|
Inari Medical, Inc. |
NARI |
Director |
2024-04-24 |
541,149 |
2024-04-24 |
335 |
Premium* |
|
|
Silverback Therapeutics, Inc. |
SBTX |
Director |
2021-12-13 |
95,238 |
2021-12-13 |
0 |
Premium* |
|
|
Edgewise Therapeutics, Inc. |
EWTX |
Director |
2022-02-25 |
15,625 |
2022-02-25 |
0 |
Premium* |
|
|
Effector Therapeutics Ord Shs |
EFTR |
10% Owner |
2021-08-25 |
0 |
2022-08-03 |
127,569 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NARI |
Inari Medical, Inc. |
Director |
• • – |
2024-04-24 |
4 |
A |
$42.41 |
$174,984 |
D/D |
4,126 |
541,149 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
Director |
• • – |
2023-05-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,982 |
537,023 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
Director |
• • – |
2023-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,412 |
534,041 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
10% Owner |
– – • |
2022-08-03 |
4 |
S |
$0.80 |
$47,738 |
I/I |
(59,376) |
127,569 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
10% Owner |
– – • |
2022-08-02 |
4 |
S |
$0.80 |
$22,476 |
I/I |
(28,201) |
129,365 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
10% Owner |
– – • |
2022-08-01 |
4 |
S |
$0.79 |
$20,989 |
I/I |
(26,703) |
130,218 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
10% Owner |
– – • |
2022-07-28 |
4 |
S |
$0.89 |
$29,005 |
I/I |
(32,517) |
131,025 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
10% Owner |
– – • |
2022-07-27 |
4 |
S |
$0.89 |
$38,949 |
I/I |
(43,665) |
132,009 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
10% Owner |
– – • |
2022-07-26 |
4 |
S |
$0.90 |
$2,509 |
I/I |
(2,775) |
133,330 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
10% Owner |
– – • |
2022-07-25 |
4 |
S |
$0.93 |
$2,122 |
I/I |
(2,279) |
133,414 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
10% Owner |
– – • |
2022-07-22 |
4 |
S |
$0.91 |
$6,929 |
I/I |
(7,614) |
133,483 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
10% Owner |
– – • |
2022-07-21 |
4 |
S |
$0.96 |
$2,545 |
I/I |
(2,665) |
133,714 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
10% Owner |
– – • |
2022-07-20 |
4 |
S |
$1.00 |
$10,040 |
I/I |
(10,030) |
133,795 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
10% Owner |
– – • |
2022-07-19 |
4 |
S |
$1.00 |
$2,754 |
I/I |
(2,754) |
134,099 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
10% Owner |
– – • |
2022-07-18 |
4 |
S |
$1.08 |
$22,667 |
I/I |
(20,987) |
134,183 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
10% Owner |
– – • |
2022-07-15 |
4 |
S |
$1.11 |
$50,857 |
I/I |
(45,900) |
134,818 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
Director |
• • – |
2022-05-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,983 |
531,629 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
Director |
• • – |
2022-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
2,420 |
528,646 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
10% Owner |
– – • |
2022-05-19 |
4 |
S |
$1.69 |
$14,490 |
I/I |
(8,574) |
136,241 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
10% Owner |
– – • |
2022-05-18 |
4 |
S |
$1.73 |
$24,425 |
I/I |
(14,086) |
136,507 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
10% Owner |
– – • |
2022-05-17 |
4 |
S |
$1.75 |
$20,581 |
I/I |
(11,767) |
136,944 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
10% Owner |
– – • |
2022-05-16 |
4 |
S |
$1.75 |
$22,295 |
I/I |
(12,769) |
137,309 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
10% Owner |
– – • |
2022-05-13 |
4 |
S |
$1.84 |
$41,574 |
I/I |
(22,607) |
137,704 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
10% Owner |
– – • |
2022-05-12 |
4 |
S |
$2.00 |
$21,632 |
I/I |
(10,800) |
138,405 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
10% Owner |
– – • |
2022-05-11 |
4 |
S |
$2.35 |
$11,725 |
I/I |
(5,000) |
138,741 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
